Purchase Order 75F40121P00534
Award Date 9/2/21
Potential Completion Date 9/2/22
Potential Value $202K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to conduct a study on the duration of pertussis immunity in baboons. The contract has a ceiling value of $171,069.00 and a period of performance ending on February 28, 2025. The contract does not have a set-aside designation. MD Anderson Cancer Center is a comprehensive cancer treatment and...
- The Food and Drug Administration awarded a $911.7K firm fixed-price purchase order to The University of Texas MD Anderson Cancer Center in Houston, Texas on August 17, 2020, to conduct a five-year study evaluating the duration of pertussis immunity in baboons. Under this contract, MD Anderson will house and maintain up to 36 baboons (24 vaccinated and 12 convalescent) and collect biological samples while administering vaccines according to the statement of work requirements. The FDA's evaluation...
- The Department of Health and Human Services Food and Drug Administration awarded a $143,340.00 firm fixed price purchase order to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to conduct a one-year study on baboons that have recovered from Bordetella pertussis (whooping cough) infection. The study will assess the duration of immune responses to B. pertussis in the research animals. This award is not associated with any larger contract...
- This is a firm-fixed-price federal contract award valued at $425,645.08 from the Food and Drug Administration (FDA) to The University of Texas MD Anderson Cancer Center, a child entity of the University of Texas System. The contract is for an "IMMUNOGENICITY STUDY IN BABOONS FOLLOWING VACCINATION WITH EXPERIMENTAL ACELLULAR PERTUSSIS VACCINES" and does not have a set-aside designation. MD Anderson, a leading academic cancer research and treatment institution, has extensive experience...
- This is a firm fixed price purchase order issued by the Department of Health and Human Services Food and Drug Administration (FDA) to The University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System, to provide 24 age-matched, Bordetella-free weanling baboons for use in Pertussis infection and vaccination studies. The contract has a potential value of $187,360.62 and was awarded on April 19, 2019 under full and open competition, with no set-aside...
- This federal contract was awarded by the Department of Health and Human Services' Food and Drug Administration to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract, valued at $283,546.12, is for a study titled "Modular Application of Surface Technology for the Generation of Antigen-Specific T Cells." It is a definitive contract with a cost-no-fee pricing type, awarded on September 13, 2019 with a completion date of...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $123,000 firm fixed-price delivery order to The University of Texas MD Anderson Cancer Center for non-human primate acquisition, with an ultimate completion date of September 18, 2026. This delivery order, issued on September 19, 2025, represents a child contract under a larger vehicle and will be performed at NIAID's primary location in Bethesda, Maryland. The award was not designated under any small business...
- This is a federal contract award from the Office of Logistics and Acquisition Operations, a component of the National Institutes of Health (NIH), to The University of Texas M.D. Anderson Cancer Center (MD Anderson). The contract, with a ceiling value of $171,500.00, is for the acquisition, testing, transportation, and housing of non-human primate research colonies to support infectious disease and immunology studies at NIH facilities. The contract is a delivery order under a larger indefinite...
- This is a research and development contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to the University of Texas MD Anderson Cancer Center (MD Anderson), a state-controlled higher education institution and comprehensive cancer treatment and research center. The $32,129,968.00 indefinite-delivery, indefinite-quantity (IDIQ) contract, awarded on September 26, 2000, supports the acquisition, testing, transportation, and housing of non-human...
- The University of Texas MD Anderson Cancer Center was awarded a firm fixed price delivery order not to exceed $145,000 by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations. The contract concerns per diem and testing costs to support the National Institute of Allergy and Infectious Diseases OWL colony pursuant to the contract statement of work. Performance will occur in Houston, Texas through December 31, 2024. No set-aside...